Skip to main content

Urbanimmersive Acquires Real Estate Photography Agencies EGP Technovirtuel, La Clique Mobile and Graphique ID

SAINT-HUBERT, Quebec, June 30, 2021 (GLOBE NEWSWIRE) -- Urbanimmersive Inc. (“Urbanimmersive”, the “Company” or “UI”) (TSX VENTURE: UI) (OTCQB: UBMRF) is pleased to announce today having completed the acquisition of all of the outstanding shares of real estate photography agencies EGP Technovirtuel Inc. ("EGP") and Graphique ID Solutions Inc. ("Graphique ID") and all of the intangible assets of La Clique Mobile s.e.n.c. ("Clique Mobile") for an aggregated purchase price of $3.03M, including $1.77M payable in cash immediately, $100k payable in 100 days and $1.16M payable through the immediate issuance of 6.6M shares of the Company at a price of $0.175 per share. All shares issued are subject to a four-month-and-a-day hold period until October 31, 2021, with 5.7M of the shares issued subject to 18-months lock-up period until December 31, 2022. The acquisition of those three real estate photography businesses is a first step of the accelerated growth plan announced by the Company on June 22nd. Read More

from Financial Post https://ift.tt/3du78Bt

Comments

Popular posts from this blog

Photo finish: Crashing sales force Olympus to sell iconic camera business

Sometimes, the vicissitudes of capitalism force companies to exit the businesses for which they’re best known. Olympus, once a leading light in the photography industry, is now joining that list. On Wednesday, the company said it planned to quit its 84-year-old camera business. The imaging giant, known for its once-pervasive digital cameras, agreed to sell off the declining unit by year’s end. Japan Industrial Partners, a private equity firm best known for buying Sony’s struggling Vaio computer line in 2014, agreed to purchase the business. Terms of the deal were not disclosed. A glance at Olympus’s financial statements provides all the rationale for the divestiture; as at rival manufacturers, camera sales have plummeted over the past decade. For the fiscal year ended March 31, Olympus’s camera unit declined 10% versus the year prior to  ¥43.6 billion, or $407 million. The unit’s sales have collapsed by three-quarters from a decade ago, when the company brought in ¥175 billion, or $

WHO says common steroids can slash death risk for the sickest coronavirus patients

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism,  subscribe today . An old drug can learn new tricks during the coronavirus pandemic. That’s the main takeaway from the World Health Organization (WHO) in a new analysis of corticosteroids—a class of drugs which have existed for dozens of years and are far cheaper than new, experimental COVID treatments in development—suggesting that drugs like dexamethasone can slash the chances of COVID-19 related deaths by as much as 35% in the sickest patients. The WHO analysis of coronavirus drugs encompassed seven separate studies. And while an analysis of this sort—what’s called a “meta-analysis”—isn’t as rigorous as other types of trials like a randomized controlled study, the data are compelling. Corticosteroids have a very different action mechanism from many of the other coronavirus drugs in development. COVID-19 is a peculiar disease. Some who have been infected may be